SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

10 Aug 2023 Evaluate
The sales for the June 2023 quarter moved up 37.65% to Rs. 837.41 millions as compared to Rs. 608.34 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2023 zoomed to 105.01% from Rs. 38.54 millions to Rs. 79.01  millions.Operating profit for the quarter ended June 2023 rose to 361.22 millions as compared to 171.30 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 837.41 608.34 37.65 837.41 608.34 37.65 2477.02 3569.52 -30.61
Other Income 207.82 126.28 64.57 207.82 126.28 64.57 686.44 408.62 67.99
PBIDT 361.22 171.30 110.87 361.22 171.30 110.87 246.44 625.49 -60.60
Interest 67.60 26.59 154.23 67.60 26.59 154.23 208.25 90.54 130.01
PBDT 230.25 144.71 59.11 230.25 144.71 59.11 -117.27 623.04 -118.82
Depreciation 122.63 104.21 17.68 122.63 104.21 17.68 465.48 348.18 33.69
PBT 107.62 40.50 165.73 107.62 40.50 165.73 -582.75 274.86 -312.02
TAX 28.61 1.96 1359.69 28.61 1.96 1359.69 -87.93 73.27 -220.01
Deferred Tax 9.81 -5.14 -290.86 9.81 -5.14 -290.86 -4.27 25.25 -116.91
PAT 79.01 38.54 105.01 79.01 38.54 105.01 -494.82 201.59 -345.46
Equity 86.80 86.80 0.00 86.80 86.80 0.00 86.80 86.80 0.00
PBIDTM(%) 43.14 28.16 53.19 43.14 28.16 53.19 9.95 17.52 -43.22

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×